scholarly journals Benefit from a high dose of gefitinib in a woman with lung adenocarcinoma and an epidermal growth factor receptor tyrosine-kinase acquired mutation

Author(s):  
Gabriella Fontanini ◽  
Franca Melfi ◽  
Laura Boldrini ◽  
Tiziana Prochilo ◽  
Editta Baldini
Sign in / Sign up

Export Citation Format

Share Document